SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE-BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS-SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN

Response Rates and Nonresponse Errors in Surveys

(2012) Timothy P. Johnson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Value-Based Pricing

(2011) Dyfrig A. Hughes   PHARMACOECONOMICS

Comparison of Anticancer Drug Coverage Decisions in the United States and United Kingdom: Does the Evidence Support the Rhetoric?

(2010) Anne Mason et al.   JOURNAL OF CLINICAL ONCOLOGY

Value-based medicine pricing: NICE work?

(2010) David J Webb   LANCET

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

(2010) MP Coleman et al.   LANCET

Pharmacoeconomics: NICE's approach to decision-making

(2009) Michael Rawlins et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Severity of illness and priority setting in healthcare: A review of the literature

(2009) Koonal K. Shah   HEALTH POLICY

Health State Utilities: A Framework for Studying the Gap Between the Imagined and the Real

(2007) Anne M. Stiggelbout et al.   VALUE IN HEALTH